EquiCeutica

The company management structure is founded on expertise and success. The key players combine scientific, veterinary and business acumen enabling EquiCeutica to be the global market pioneer for this game-changing product field. Our objective is to be the market leader in Veterinary & Human medicinal CBD products as the first company to secure regulatory authorisations across a range of species and conditions. A secure pathway of product provision, processing and distribution is in place to allow EquiCeutica to take the product to the user. EquiCeutica’s certified FDA, GMP and TGA (Australia), with ANVISA (Brazil) accreditation, active pharmaceutical ingredient provides pharmaceutical grade CBD for EquiCeutica products.